Susan Ivy
Pediatric Hematology-Oncology · Washington, DCNPI 1972681120
Payments from drug & device makers
What this record shows
That places this record below the midpoint for pediatric hematology-oncology clinicians in DC, where the typical reported total is $305.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
Across 27 payments — averaging $372,615 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$5.3M
- Pfizer$4.7M
- Janssen Research & Development, LLC$68K
How this compares
$0 in reported general payments places this provider in the 10th percentile of 46 pediatric hematology-oncology providers in District of Columbia.
See all pediatric hematology-oncology providers in District of Columbia →
Other pediatric hematology-oncology in Washington
- Caterina MinnitiWashington$478K
- Michael GuerreraWashington$314K
- Deepika DarbariWashington$97K
- Naomi LubanWashington$27K
- Holly MeanyWashington$23K
- Anne AngiolilloWashington$22K
- Eugene HwangWashington$21K
- Gary KupferWashington$21K
- Catherine BollardWashington$15K
- James TaylorWashington$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.